Impact of Early Administration of Evidence-based Antithrombotic and Antiplatelet Therapy in Patients with High-risk Non-ST-segment Elevation Acute Coronary Syndrome

2005 ◽  
Vol 12 (Supplement 1) ◽  
pp. 85-85
Author(s):  
C. V. Pollack
2009 ◽  
Vol 133 (1) ◽  
pp. 32-40 ◽  
Author(s):  
Nicolas Danchin ◽  
François Diévart ◽  
Jean-François Thébaut ◽  
Olivier Grenier ◽  
Esvet Mihci ◽  
...  

2013 ◽  
Vol 167 (6) ◽  
pp. 2580-2587 ◽  
Author(s):  
Renato D. Lopes ◽  
Jennifer A. White ◽  
Pierluigi Tricoci ◽  
Harvey D. White ◽  
Paul W. Armstrong ◽  
...  

2020 ◽  
Vol 25 (8) ◽  
pp. 3812
Author(s):  
T. S. Golovina ◽  
Yu. N. Neverova ◽  
R. S. Tarasov

The feasibility of dual antiplatelet therapy as early as possible in patients with ST-segment elevation acute coronary syndrome, where percutaneous coronary intervention is recommended, has been proven: it improves treatment outcomes by reducing the risk of adverse ischemic events, including stent thrombosis and myocardial infarction.This article provides a detailed analysis of the evidence data and current recommendations on the validity and timing of dual antiplatelet therapy for acute coronary syndrome. The emphasis is made on the controversy regarding the early dual antiplatelet therapy in non-ST-segment elevation acute coronary syndrome. The rationale for using dual antiplatelet therapy only after coronary angiography and determining the revascularization strategy is described, which should increase the accessibility of coronary artery bypass graft surgery for patients.


2020 ◽  
Vol 2020 ◽  
pp. 1-9
Author(s):  
Zhaofeng Shi ◽  
Chen Zhao ◽  
Manke Guan ◽  
Xuxu Wei ◽  
Jiayuan Hu ◽  
...  

Background. Non-ST segment elevation acute coronary syndrome has been one of the most serious diseases threatening human health. Long-term cardiac rehabilitation and secondary prevention is the essential method to control the recurrence and mortality of the disease. Traditional Chinese medicine has proved the efficiency on the treatment of non-ST segment elevation acute coronary syndrome, but there is a lack of appropriate methodological design to reflect the characteristics of individualized diagnosis and treatment of it. Therefore, this study used the evidenced-based Goal Attainment Scale to evaluate the clinical effectiveness of traditional Chinese medicine on the treatment of non-ST segment elevation acute coronary syndrome. Method. This is observational research with the prospective feature. A total of 200 patients will be recruited and observed in the three months by telephone or door visit, collecting the individualized intervention of traditional Chinese medicine and evaluating through the method of evidence-based Goal Attainment Scale. Participants will be included according to the inclusion and exclusion criteria. Any reasons for loss to follow-up and adverse events will be recorded strictly. Discussion. The evidence-based Goal Attainment Scale provides a personalized method of evaluation based on the Goal Attainment Scale and combined with evidence-based medicine, which can better reflect the characteristics and superiority of individualized and dynamic intervention for traditional Chinese medicine on the long-term prevention and treatment of non-ST segment elevation acute coronary syndrome than other methods of design. It is of great significance to explore and promote this method of design in the future.


2013 ◽  
Vol 83 (5) ◽  
pp. 677-683 ◽  
Author(s):  
Roy Beigel ◽  
Shlomi Matetzky ◽  
Natalie Gavrielov-Yusim ◽  
Paul Fefer ◽  
Shmuel Gottlieb ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document